World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9149)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

435

WORD

130

HTML

4461

Figures (1-1)

986

Tables (1-3)

722

Sum=6734

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

270

Download

963

Sum=1233

Publishing Process of This Article

Item

Count

Browse

302

Download

896

Sum=1198

Jan 15, 2023 (publication date) through Jan 9, 2026

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Liang J, Bai Y, Ha FS, Luo Y, Deng HT, Gao YT. Combining local regional therapy and systemic therapy: Expected changes in the treatment landscape of recurrent hepatocellular carcinoma. World J Gastrointest Oncol 2023; 15(1): 1-18 [PMID: 36684055 DOI: 10.4251/wjgo.v15.i1.1]
URL:	https://www.wjgnet.com/1007-9327/full/v15/i1/1.htm

Number	Citing Articles
1	Changlong Hou, Baizhu Xiong, Lei Zhou, Yipeng Fei, Changgao Shi, Xianhai Zhu, Tao Xie, Yulin Wu. Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12144-6
2	Ming-Zhi Hao, Hai-Lan Lin, Yu-Bin Hu, Qi-Zhong Chen, Zhang-Xian Chen, Lin-Bin Qiu, Duan-Yu Lin, Hui Zhang, De-Chun Zheng, Zhu-Ting Fang, Jing-Feng Liu. Combination therapy strategy based on selective internal radiation therapy as conversion therapy for inoperable giant hepatocellular carcinoma: A case report. World Journal of Gastrointestinal Oncology 2025; 17(3): 100861 doi: 10.4251/wjgo.v17.i3.100861 Abstract(333) \| Core Tip(343) \| Full Article(HTML)(1529) \| Full Article with Cover (PDF)-7010K(87) \| Audio-787K(20) \| Peer-Review Report-223K(69) \| Answering Reviewers-79K(90) \| Full Article (PDF)-6723K(183) \| Full Article (XML)-84K(80) \| Times Cited (0) \| Total Visits (4110) \| Open
3	Beichuan Pang, Bangyou Zuo, Liang Huang, Xinyu You, Tao Liu, Jianjie Hao, Chengxiang Yuan, Chong Yang, Wan Yee Lau, Yu Zhang. Real-world efficacy and safety of TACE-HAIC combined with TKIs and PD-1 inhibitors in initially unresectable hepatocellular carcinoma. International Immunopharmacology 2024; 137: 112492 doi: 10.1016/j.intimp.2024.112492
4	Yutao Chen, Desheng Chen, Zhixing Liang, Haoyuan Yu, Haobin Sun, Yongwei Hu, Peng Jiang, Mingshen Zhang, Linsen Ye, Hua Li. Immune checkpoint inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies. Cancer Drug Resistance 2025; doi: 10.20517/cdr.2025.120